In briefBMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39510.633970.DB (Published 06 March 2008) Cite this as: BMJ 2008;336:524
US drug industry spent $22m (£11m; €14m) on lobbying in 2007: Pharmaceutical Research and Manufacturers of America, which represents pharmaceutical research and biotechnology companies, increased its spending on lobbying the federal government in 2007 by 25% from the previous year’s figure. Last year it lobbied Congress to expand children’s health insurance and against a proposal that would have allowed the government to negotiate drug prices for elderly people. It also lobbied against legislation that would have …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial